To describe the prevalence, associated risk factors and outcomes of serious neurologic manifestations among patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, researchers studied 16,225 patients from 179 hospitals in 24 countries as part of the Society for Critical Care Medicine’s Viral Infection and Respiratory Illness University Study.
